Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis

被引:85
作者
Vikhanskaya, F
Vignati, S
Beccaglia, P
Ottoboni, C
Russo, P
D'Incalci, M
Broggini, M
机构
[1] Mario Negri Inst Pharmacol Res, Mol Pharmacol Unit, Dept Oncol, I-20157 Milan, Italy
[2] Ist Nazl Ricerca Cancro, Dept Expt Oncol, Genoa, Italy
关键词
D O I
10.1006/excr.1998.4018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Paclitaxel-induced cytotoxicity, cell cycle perdurbation, and apoptosis were determined in a human ovarian cancer cell Line expressing wt p53 (A2780) and in a subclone (A2780/E6) obtained upon transfection with the product of the E6 gene of the human papilloma virus HPV16. The inactivation of wt p53 in A2780/E6 was verified by measuring the inability of the clone to induce p53 and p21 expression after paclitaxel treatment. The p53-negative clone (A2780/E6) was approximately 50-fold more sensitive to paclitaxel than wt p53-expressing A2780 cells. This increased sensitivity was related to the ability of paclitaxel to induce a strong arrest of cells in the G2/M phase of the cell cycle in A2780/E6 but not in A2780 cells. This different cell cycle arrest was accompanied by increased frequency of paclitaxel-induced p53-independent apoptosis, Initial studies on proteases activation tend to exclude a direct role of ICE: and CPP32 in the induction of apoptosis in these cells and show a paclitaxel-dependent increase in FLICE levels, whose biological relevance is however at present not defined. (C) 1998 Academic Press.
引用
收藏
页码:96 / 101
页数:6
相关论文
共 39 条
[31]   SENSITIVITY AND CELLULAR-RESPONSE TO DIFFERENT ANTICANCER AGENTS OF A HUMAN OVARIAN-CANCER CELL-LINE EXPRESSING WILD-TYPE, MUTATED OR NO P53 [J].
SIRE, EAG ;
VIKHANSKAYA, F ;
BROGGINI, M .
ANNALS OF ONCOLOGY, 1995, 6 (06) :589-593
[32]  
TISHLER RB, 1995, CANCER RES, V55, P6021
[33]   DECREASED CYTOTOXIC EFFECTS OF DOXORUBICIN IN A HUMAN OVARIAN CANCER-CELL LINE EXPRESSING WILD-TYPE P53 AND WAF1/CIP1 GENES [J].
VIKHANSKAYA, F ;
DINCALCI, M ;
BROGGINI, M .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (03) :397-401
[34]  
Vikhanskaya F, 1997, INT J CANCER, V72, P155, DOI 10.1002/(SICI)1097-0215(19970703)72:1<155::AID-IJC22>3.3.CO
[35]  
2-B
[36]   Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis [J].
Wahl, AF ;
Donaldson, KL ;
Fairchild, C ;
Lee, FYF ;
Foster, SA ;
Demers, GW ;
Galloway, DA .
NATURE MEDICINE, 1996, 2 (01) :72-79
[37]  
WALDMAN T, 1995, CANCER RES, V55, P5187
[38]   TAXOL-INDUCED MITOTIC BLOCK TRIGGERS RAPID ONSET OF A P53-INDEPENDENT APOPTOTIC PATHWAY [J].
WOODS, CM ;
ZHU, J ;
MCQUENEY, PA ;
BOLLAG, D ;
LAZARIDES, E .
MOLECULAR MEDICINE, 1995, 1 (05) :506-526
[39]   P53 and chemosensitivity [J].
Wu, GS ;
ElDeiry, WS .
NATURE MEDICINE, 1996, 2 (03) :255-256